Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2206 in Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
NCT01604772Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-2206 in adenoid cystic carcinoma (ACC), sponsored by National Cancer Institute. Started Jul 2012; status: completed.
02
Drugs
MK-2206
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01604772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604772.